Minimal Residual Disease Assessment and Allogeneic Transplantation As Consolidation Therapy in Acute Lymphoblastic Leukemia

Minimal Residual Disease Assessment and Allogeneic Transplantation as Consolidation Therapy in Acute Lymphoblastic Leukemia Abstract Introduction: Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse (1-4). C...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2020-11, Vol.136 (Supplement 1), p.7-8
Hauptverfasser:	Combariza, Jf, Bautista Toloza, Leonardo, Arango, M, Diaz, L, Agudelo Lopez, Claudia, Avila, Vladimir, Hernandez, Sonia Milena, León-Basantes, Guillermo, Madera Rojas, Ana Maria, valdés-Cespedes, Jaime, Mejia, Fabián, Moreno, Liliana, Orduz R, Rocio, Tovar-Bobadilla, Jl, Ramirez, Carlos Alberto
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!